Global Gel Electrophoresis Equipment Market - 2022-2029

Global Gel Electrophoresis Equipment Market - 2022-2029

Market Overview

Gel Electrophoresis Equipment Market size was valued US$ 2.1 billion in 2021 and is estimated to reach US$ 3.5 billion by 2029, growing at a CAGR of 5.5% during the forecast period (2022-2029).

Gel electrophoresis is a process that is used to isolate mixtures based on their molecular size, including deoxyribonucleic acid (DNA), proteins, and ribonucleic acid (RNA). The gel electrophoresis equipment applies an electrical charge to molecules, forcing them to travel toward their oppositely charged electrode. The method is found in all clinical and research laboratories using protein and DNA applications. Additionally, Gel Electrophoresis equipment comprises vertical gel equipment for protein separation and horizontal gel electrophoresis units for DNA separation.

Market Dynamics

The global gel electrophoresis equipment market is growing due to several factors such as growing demand for innovative therapies and drugs coupled with increasing research projects related to genes, proteins, & certain biomolecules, increasing technological advancements in the equipment, and among others.

Rising incidence of cancer, infectious diseases, and genetic disorders are expected to drive market growth.

The rising demand for early diagnosis and remedial treatment of life-threatening diseases increases the number of R&D programs aimed at the development of innovative genetic technologies and novel products. This has increased private and public investments and government funds, and grants for specific disease-targeted genomic research. Increasing government funding towards genomics is one of the major factors leading to the gel electrophoresis market growth. Genomic researchers are increasingly opting for electrophoresis techniques due to their reliability. Genomics research is driven by government and nonprofit funding sources, augmented by private research and development (R&D) funding. For instance, the National Human Genome Research Institute (NHGRI) funds and collaborates with scientists in government, public, and private institutions.

The United States spends the most compared to other countries on genomics research, corresponding to 40% worldwide public funding. Citizens and taxpayers of several countries have funded much of the research and have expectations about access to the resulting information and knowledge. While access to knowledge gained from all publicly funded research is desired, access is essential for fields that have a broad social impact and stimulate public dialogue. Innovate UK has up to £5 million to support capital investment in equipment that increases the UK’s capacity to produce and commercialize genomic analysis technologies. Genomics is a field where public concerns are raised for health care and insurance implications and personal and ancestral identification.

Presence of alternative technologies offering better efficiency are expected to hamper the market growth.

The gel electrophoresis market growth can be hindered, as it a time-consuming technique and provides limited sample analysis. Along with this presence of alternative technologies offering better efficiency & results can also affect the market growth.

Industry Analysis

The global Gel Electrophoresis Equipment market provides in-depth analysis of the market based on various industry factors such as Porter’s Five Forces, Regulatory Analysis, Supply Chain Analysis, Pricing Analysis, Unmet Needs, Product Development.

Segment Analysis/B>

Polyacrylamide gel segment is expected to hold the largest market share in global gel electrophoresis equipment market

Based on electrophoresis equipment market is segmented into Polyacrylamide Gel, Agarose Gel, and others. Among these based on the gel-type, the Polyacrylamide Gel is expected to grow at the fastest growth rate over the forecast period. Polyacrylamide gel electrophoresis (PAGE) is a technique used to separate proteins based on their size. In polyacrylamide gel electrophoresis, an anionic detergent, sodium dodecyl sulfate (SDS), is used for binding to proteins and give a negative charge to them. After that, proteins are separated electrophoretically based on their size using a polyacrylamide gel matrix in an electric field. The polyacrylamide is produced due to the polymerization reaction between acrylamide and N, N'-methylene-bisacrylamide (BIS) using a catalyst. The degree of polymerization or cross-linking can be controlled by adjusting the concentration of acrylamide and BIS. The more cross-linking, the harder the gel. The hardness of the gel, in turn, modulates the friction experienced by macromolecules when they travel through the gel during PAGE, thus affecting the resolution of separation.

The market is segmented into diagnostics, research, quality control & process validation, and others based on gel electrophoresis applications. Among these, quality control & process validation is expected to grow at the highest growth rate during the forecast period, owing to the rising use of electrophoresis in quality control of pharmaceutical formulations by analysing pharmaceutical formulations' drug content. Also, the hemoglobin analysis is expected to grow at a significant growth rate over the forecast period. Hemoglobin electrophoresis is one of the most accurate, precise, and regularly used DNA analysis techniques worldwide. Gel electrophoresis equipment is expected to have large opportunities as a major application in the analysis of hemoglobin.

Geographical Analysis

North America region holds the largest market share in the global gel electrophoresis equipment market

North America is dominating the global gel electrophoresis equipment market accounted for the largest market share, owing to the high presence of major pharmaceutical and biotechnology players in this region. The pharmaceutical and biotechnology & companies are constantly focusing on developing new drugs owing to which there is a high demand for electrophoresis equipment. Also, the increasing research projects based on proteins, associated biomolecules, and genes, increasing focus on the development of structure-based drug designs, stringent regulatory requirements about pharmaceutical manufacturing necessitating quality control and process validation processes, and expanding research activities in the fields of genomics and proteomics are contributing to the growth of the market in this region.

The United States is dominating the gel electrophoresis market in this region, owing to the rising support and funding activities by the government and non-government organizations. By supporting genomics research, various government bodies, like NHGRI (National Human Genome Research Institute), have supported sequencing the human genome and fund research on its structure, function, and health disease role. They also support studies on the ethical, legal, and social implications (ELSI) of genome research.

Competitive Landscape

The global gel electrophoresis equipment market is competitive, with major players competing and emerging players. Some of the market's major players include Thermo Fisher Scientific Inc., SERVA Electrophoresis GmbH, General Electric Company, Agilent Technologies, Bio-Rad Laboratories Inc., Hoefer Inc., Beckman Coulter Inc., Lonza Group Ltd., C.B.S Scientific Company Inc. and among others.

The key players adopt various growth strategies such as product launches and collaborations, contributing to the gel electrophoresis equipment market's growth globally. For instance,

On Jun 2021, Thermo Fisher Scientific and Advanced Electrophoresis Solutions Ltd announced their agreement in which they will advance therapeutic protein development by combining the mass spectrometry with important protein separation techniques.

In May 2020, Bio-Rad Laboratories, Inc., introduces GelDoc imaging system which is used for imaging and documentation of proteins and nucleic acids suspended in agarose and the polyacrylamide gels.

Key Companies to Watch

GE Healthcare:

Overview: GE HealthCare is a subsidiary of General Electric an American multinational conglomerate integrated in New York, founded in 1994 and headquartered in Chicago, Illinois. It manufactures and distributes various diagnostic imaging agents and radiopharmaceuticals that can be used for imaging modalities in some procedures such as medical imaging.

Product Portfolio:

Amersham ECL Gel System: Key objective is to make Poly acrylamide gel electrophoresis as easier as DNA gel electrophoresis. As its horizontal so sample application gets easier doesn’t require assembly so reduce the preparation time.

Key Developments: In Aug 2021 GE Healthcare and Amazon Web Services partnered to provide AI and cloud-based imaging solution to the hospitals and the healthcare providers.

The global gel electrophoresis equipment market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.